最新报道:Litecoin-based pharmaceutical firm Remedy Pharmaceuticals has secured a deal to establish a $100 million LTC treasury, aiming to leverage blockchain for healthcare financing. The company plans to use the Litecoin blockchain to enhance transparency and efficiency in funding pharmaceutical research and development. CEO John Smith stated that this initiative will streamline investment processes and ensure secure, traceable transactions. The treasury will also support partnerships with global healthcare providers to accelerate drug development. This move marks a significant step in integrating cryptocurrency with the pharmaceutical industry, potentially setting a precedent for future blockchain applications in healthcare funding.